Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
Phathom Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 12, 2024
Phathom Pharmaceuticals reported fiscal year 2023 executive compensation information on April 12, 2024.
In 2023, three executives at Phathom Pharmaceuticals received on average a compensation package of $2.4M, a 30% decrease compared to previous year.
Average pay of disclosed executives at Phathom Pharmaceuticals
Terrie Curran, Chief Executive Officer, received $3.4M in total, which decreased by 32% compared to 2022. 40% of Curran's compensation, or $1.4M, was in stock awards. Curran also received $518K in non-equity incentive plan, $831K in option awards, $688K in salary, as well as $17K in other compensation.
Azmi Nabulsi, Chief Operating Officer, received a compensation package of $2M, which decreased by 26% compared to previous year. 38% of the compensation package, or $764K, was in stock awards.
Molly Henderson, Chief Financial and Business Officer, earned $1.9M in 2023, a 29% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2024.